Severe rash associated with vemurafenib administration following nivolumab therapy

MeSH terms

• Adult
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Exanthema / chemically induced*
• Female
• Humans
• Indoles / administration & dosage
• Indoles / adverse effects*
• Lung Neoplasms / secondary
• Melanoma / drug therapy*
• Melanoma / pathology
• Nivolumab
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / pathology
• Sulfonamides / administration & dosage
• Sulfonamides / adverse effects*
• Vemurafenib